The FDA approved a single-use, battery-powered, iontophoretic transdermal system to deliver sumatriptan for the acute treatment of adult migraine with or.
Zelrix Transdermal Patch For Migraines
M2. 07 is being investigated as a potential treatment to provide rapid relief of migraine symptoms, at any time in the migraine cycle, in a discreet and simple manner. Zosano Pharma has developed its proprietary transdermal delivery system to administer novel formulations of existing drugs through the skin for the treatment of a variety of indications.
The Company’s transdermal delivery system offers rapid and consistent drug delivery, improved ease of use and room- temperature stability, all of which are benefits that the Company believes are often unavailable using oral formulations or injections and offer important therapeutic and practical advantages that address unmet needs with large patient populations. By focusing the Company’s development efforts on the delivery of established molecules with known safety and efficacy, Zosano Pharma anticipates a reduction in clinical and regulatory risk and development costs and acceleration in time to commercialization.
Sumatriptan transdermal (skin patch) is used to treat acute migraine headaches with or without aura in adults. It is not used to prevent migraine headaches. The Food and Drug Administration (FDA) has approved Zecuity, a transdermal patch, for the treatment of migraines with or without auras. The single-use, battery.
- Innovative delivery systems for migraine.
- Zosano Pharma’s goal is to enhance the therapeutic benefits of proven medications by using its novel transdermal drug delivery platform to deliver drugs rapidly.